Together, these findings indicate that expression of NTSR2 in leukemic patients results from NTRK2 overexpression, and vice versa, providing a molecular mechanism that could explain NTSR2 overexpression in B-CLL. This evidence concerns the gene NTSR2 and B-cell chronic lymphocytic leukemia.